Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer

Biotechnic and Histochemistry

Volumn 87, Issue 1, 2012, Pages 24-29

  Findeis Hosey, J J ^a   Xu, H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Dysplasia; IGF2BP3; IMP3; KOC; L523S; Lung; Malignancy; NETL; Neuroendocrine tumor; Oncoprotein; Squamous cell carcinoma

Indexed keywords

IMP3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; NEUROENDOCRINE TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 83755224706     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2011.591831     Document Type: Article

References (22)

1. Bellezza, G, Cavaliere A, Sidoni A (2009) IMP3 expression in non-small cell lung cancer. Hum. Pathol. 40: 1205-1206.
2. Findeis-Hosey JJ, Xu H (2011) The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology. Hum. Pathol. 42: 303-314.
3. Findeis-Hosey JJ, Yang Q, McMahon LA, Spaulding BO, Li F, Xu H (2010) IMP3: An immunohistochemical marker for invasive squamous cell carcinoma and its high-grade precursor lesions of the lung. Mod. Pathol. 23: 402A.
4. Findeis-Hosey JJ, Yang Q, McMahon LA, Spaulding BO, Li F, Xu H (2010) Usefulness of EZH2 and IMP3 in discriminating high grade neuroendocrine carcinoma from carcinoids in small biopsies and fi ne needle aspiration specimens of the lung. Mod. Pathol. 23: 401A.
5. Findeis-Hosey JJ, Yang Q, Spaulding BO, Wang HL, Xu H (2010) IMP3 expression is correlated with histologic grade of lung adenocarcinoma. Hum. Pathol. 41: 477-484.
6. Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED (2008) External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 112: 1471-1479. (Pubitemid 351441159)
7. Jeng YM, Chang CC, Hu FC, Chou HY, Kao HL, Wang TH, Hsu HC (2008) RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotestumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 48: 1118-1127.
8. Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, Wu CL (2008) Combination of quantitative IMP3 and tumor stage: A new system to predict metastasis for patients with localized renal cell carcinomas. Clin. Cancer Res. 14: 5579-5584.
9. Jiang Z, Chu PG, Woda BA, Rock KL, Liu Q, Hsieh CC, Li C, Chen W, Duan HO, McDougal S, Wu CL (2006) Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: A retrospective study. Lancet Oncol. 7: 556-564. (Pubitemid 43923666)
10. Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA, Rock KL, Kwon ED (2008) Oncofetal protein IMP3: A novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer 112: 2676-2682. (Pubitemid 351969211)
11. Liao B, Hu Y, Herrick DJ, Brewer G (2005) The RNAbinding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J. Biol. Chem. 280: 18517-18524. (Pubitemid 41389102)
12. Mohanty SK, Lu DI, Dresser K, Jiang Z (2008) An oncofetal protein, IMP3: A novel biomarker to predict tumor progression in the low grade Ta urothelial carcinoma of the bladder. Mod. Pathol. 21: 171A.
13. Mueller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Hameister H, Varga G, Friess H, Buchler M, Beger HG, Vila MR, Adler G, Gress TM (1997) Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 14: 2729-2733. (Pubitemid 27283112)
14. Mueller-Pillasch F, Pohl B, Wilda M, Lacher U, Beil M, Wallrapp C, Hameister H, Knochel W, Adler G, Gress TM (1999) Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech. Dev. 88: 95-99. (Pubitemid 29467415)
15. Nielsen J, Christiansen J, Lykke-Andersen J, Johnson AH, Wewer UM, Nielsen FC (1999) A family of insulin-likegrowth factor II mRNA-binding proteins represses translation in late development. Mol. Cell Biol. 19: 1262-1270. (Pubitemid 29046868)
16. Schaeffer DF, Owen D, Lim HJ, Mehl E, Buczkowski AK, Chung SW, Scudamore CH, Owen DA, Ng SSW, Huntsman DG (2009) Insulin-like growth factor-2 mRNA binding protein 3 (IGF2BP3) expression may be a marker for an unfavorable prognosis in pancreatic ductal adenocarcinoma. Mod. Pathol. 22: 321A.
17. Sitnikova L, Mendese G, Liu Q, Woda BA, Lu D, Dresser K, Mohanty S, Rock KL, Jiang Z (2008) IMP3 predicts aggressive superfi cial urothelial carcinoma of the bladder. Clin. Cancer Res. 14: 1701-1706. (Pubitemid 351469454)
18. Vikesaa J, Hansen TV, Jonson L, Borup R, Wewer UM, Christiansen J, Nielsen FC (2006) RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 25: 1456-1468.
19. Vohra P, Cagle PT, Allen TC, Dresser K, Chakraborty S, Fraire AE (2008) Tissue microarray study of RNA-binding protein IMP3 in primary non-small cell lung cancers: Prediction of survival in early stage squamous cell carcinomas. Mod. Pathol. 21: 352A.
20. Wang T, Fan L, Watanabe Y, McNeill PD, Moulton GG, Banger C, Fanger GR, Okada M, Inoue Y, Persing DH, Reed SG (2003) L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br. J. Cancer 88: 887-894. (Pubitemid 36520876)
21. Xu H, Bourne PA, Spaulding BO, Wang HL (2007) Highgrade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum. Pathol. 38: 555-563. (Pubitemid 46399894)
22. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K (2005) KOC (K homology domain containing protein overexpressed in cancer): A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am. J. Surg. Pathol. 29: 188-195. (Pubitemid 40170636)